Allan Perel is a Neurology physician affiliated with Richmond University Medical Center. OpenAlex indexes 15 publications with 854 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
133 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
133 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
75.5%Neuromuscular Blocker73.9%Onabotulinumtoxina100%Botox0%Part D + Part B<11 patientsgamma-Aminobutyric Acid-ergic Agonist0.6%Baclofen100%Part D≥33 patients+ 3 more classes in this area
Nervous system
22.1%Gabapentinoids4.7%Gabapentin82%Pregabalin18%Part D≥198 patientsCholinesterase Inhibitor3%Donepezil Hcl87%Rivastigmine6%Adlarity4%Pyridostigmine Bromide3%Part D<11 patients+ 32 more classes in this area
Cancer & immunology
0.9%Other immunosuppressants0.5%Vumerity60%Dimethyl Fumarate23%Tecfidera17%Part D<11 patientsOther immunostimulants0.2%Copaxone63%Glatiramer Acetate37%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age
Multiple Sclerosis and Related Disorders
2021 - Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium
Multiple Sclerosis Journal
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Francesco Rotatori, MD
Richmond University Medical Center
Hoon Lee, MD
Richmond University Medical Center
Victoria Forte, MD
Richmond University Medical Center
Keith Diaz, MD
Richmond University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”